Login / Signup
Your account is not claimed yet. You can
sign up with ORCID
to claim your account.
Andreas Johne
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Brain Metastases
Epidermal Growth Factor Receptor
Small Cell Lung Cancer
Squamous Cell Carcinoma
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Joachim Albers
,
Manja Friese-Hamim
,
Anderson Clark
,
Oliver Schadt
,
Gina Walter-Bausch
,
Christopher Stroh
,
Andreas Johne
,
Niki Karachaliou
,
Andree Blaukat
The preclinical pharmacology of tepotinib - a highly selective MET inhibitor with activity in tumors harboring MET alterations.
Molecular cancer therapeutics
(2023)
Chong-Kin Liam
,
Azura Rozila Ahmad
,
Te-Chun Hsia
,
Jian-Ying Zhou
,
Dong Wan Kim
,
Ross Andrew Soo
,
Ying Cheng
,
Shun Lu
,
Sang Won Shin
,
James Chih-Hsin Yang
,
Yiping Zhang
,
Jun Zhao
,
Karin Berghoff
,
Rolf Bruns
,
Andreas Johne
,
Yi-Long Wu
Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)